Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2341 AL 2355

Hybrid Imaging of Vascular Cognitive Impairment

Frantellizzi V, Conte M, De Vincentis G.

Semin Nucl Med. 2021 May;51(3):286-295. doi: 10.1053/j.semnuclmed.2020.12.006. Epub 2020 Dec 20.

Alzheimer Disease Spectrum: Syndrome and Etiology From Clinical and PET Imaging Perspectives

Knopman DS, Jagust WJ.

Neurology. 2021 Feb 16;96(7):299-300. doi: 10.1212/WNL.0000000000011415. Epub 2020 Dec 22.

Zingiber officinale ameliorates Alzheimer's disease and Cognitive Impairments: Lessons from preclinical studies

Talebi M, İlgün S, Ebrahimi V, Talebi M, Farkhondeh T, Ebrahimi H, Samarghandian S.

Biomed Pharmacother. 2021 Jan;133:111088. doi: 10.1016/j.biopha.2020.111088. Epub 2020 Dec 15.

Pathobiological Subtypes of Alzheimer Disease

Jellinger KA.

Dement Geriatr Cogn Disord. 2020;49(4):321-333. doi: 10.1159/000508625. Epub 2021 Jan 11.

Immunological and hormonal mechanisms in Alzheimer's disease

Trifu SC, Ţîbîrnă A, Drăgoi AM, Cristea BM.

Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1033-1038. doi: 10.47162/RJME.61.4.05.

Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease

Shi Y, Gu L, Wang Q, Gao L, Zhu J, Lu X, Zhou F, Zhu D, Zhang H, Xie C, Zhang Z.

J Gerontol A Biol Sci Med Sci. 2020 Mar 9;75(4):664-670. doi: 10.1093/gerona/glz005.

The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia

Hazen J, Vistnes M, Barca ML, Eldholm RS, Persson K, Brækhus A, Saltvedt I, Selbæk G, Engedal K, Knapskog AB.

Alzheimer Dis Assoc Disord. 2020 Jan-Mar;34(1):47-53. doi: 10.1097/WAD.0000000000000342.

Current opinion neurology: visual pathway biomarkers in Alzheimer's disease

Van Stavern GP.

Curr Opin Neurol. 2020 Feb;33(1):79-86. doi: 10.1097/WCO.0000000000000788.

Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice

Shaw LM, Korecka M, Figurski M, Toledo J, Irwin D, Hee Kang J, Trojanowski JQ.

J Appl Lab Med. 2020 Jan 1;5(1):183-193. doi: 10.1373/jalm.2019.029587.

Developing robust biomarkers for vascular cognitive disorders: adding 'V' to the AT(N) research framework

Sachdev PS.

Curr Opin Psychiatry. 2020 Mar;33(2):148-155. doi: 10.1097/YCO.0000000000000577.

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ.

Alzheimers Dement. 2020 Jan;16(1):229-243. doi: 10.1002/alz.12006.

Blood-based Biomarkers of Alzheimer's Disease: The Long and Winding Road

Manzine PR, Vatanabe IP, Peron R, Grigoli MM, Pedroso RV, Nascimento CMC, Cominetti MR.

Curr Pharm Des. 2020;26(12):1300-1315. doi: 10.2174/1381612826666200114105515.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias